Privia Health Group, Inc.

NASDAQ:PRVA

23.75 (USD) • At close March 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 460.9437.921422.326415.243440.828417.282413.351386.276364.424342.899335.536313.801275.333251.524225.756213.607213.699207.17183.264212.942
Cost of Revenue 412.933392.569379.642374.393401.787375.546371.918346.985327.711309.013301.695283.459250.446225.369238.668188.075190.301185.673165.852192.667
Gross Profit 47.96745.35242.68440.8539.04141.73641.43339.29136.71333.88633.84130.34224.88726.155-12.91225.53223.39821.49717.41220.275
Gross Profit Ratio 0.1040.1040.1010.0980.0890.10.10.1020.1010.0990.1010.0970.090.104-0.0570.120.1090.1040.0950.095
Reseach & Development Expenses 00000000000000000000
General & Administrative Expenses 34.42530.69528.91632.12129.627.22826.80825.95128.15632.21933.10736.1139.32133.91168.65713.99614.829.7888.41910.989
Selling & Marketing Expenses 6.4627.0476.8526.0856.2497.2415.9565.2865.1735.0884.8194.6613.84.58811.1783.1843.9622.7092.222.452
SG&A 40.88737.74235.76838.20635.84934.46932.76431.23733.32937.30737.92640.77143.12138.498179.83517.1818.78212.49710.63913.441
Other Expenses 1.8321.7971.8181.8211.7721.7311.691.341.1351.153302.861.1181.1130.4660.440.4450.4540.4570.5940.338
Operating Expenses 42.71939.53937.58640.02737.62136.234.45432.57734.46438.4639.09141.88944.23438.964180.27517.62519.23612.95411.23313.779
Operating Income 5.2485.8135.0980.8231.425.5366.9796.7142.249-4.574-5.25-11.547-19.347-12.809-193.1877.9074.1628.5436.1796.496
Operating Income Ratio 00.0130.0120.0020.0030.0130.0170.0170.006-0.013-0.016-0.037-0.07-0.051-0.8560.0370.0190.0410.0340.031
Total Other Income Expenses Net 2.7742.1642.9662.9842.8482.8940.8171.8131.1520.285-0.663-0.232-0.185-0.292-0.302-0.291-0.437-0.504-0.509-0.467
Income Before Tax 8.0227.9778.0643.8074.2688.437.7968.5273.401-4.289-5.913-11.779-19.532-13.101-193.4897.6163.7258.0395.676.029
Income Before Tax Ratio 00.0180.0190.0090.010.020.0190.0220.009-0.013-0.018-0.038-0.071-0.052-0.8570.0360.0170.0390.0310.028
Income Tax Expense 2.6553.9993.4210.7511.9442.4881.4362.125-13.447-4.8455.4686.308-7.643-2.21-20.0042-0.054-8.5610.4740.7
Net Income 4.3993.5353.4672.9842.8385.6437.2747.32417.7760.556-10.475-18.087-11.979-9.115-172.5345.3983.86416.6855.2815.414
Net Income Ratio 00.0080.0080.0070.0060.0140.0180.0190.0490.002-0.031-0.058-0.044-0.036-0.7640.0250.0180.0810.0290.025
EPS 0.0370.030.030.030.020.050.060.060.160.005-0.096-0.17-0.11-0.09-1.680.0520.0380.160.0510.053
EPS Diluted 0.0350.030.030.020.020.050.060.060.140.005-0.096-0.17-0.11-0.086-1.680.0520.0380.160.0510.053
EBITDA 7.087.616.9162.6443.1927.2678.6698.0543.384-3.421-4.085-10.429-18.234-12.342-192.7478.3524.6169.0016.7736.834
EBITDA Ratio 00.0170.0160.0060.0070.0170.0210.0210.009-0.01-0.012-0.033-0.066-0.049-0.8540.0390.0220.0430.0370.032